AbbVie Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $75.96B | $15.41B | $9.75B |
| FY2022 | $63.13B | $17.25B | $9.20B |
| FY2023 | $59.25B | $10.36B | $12.81B |
| FY2024 | $66.84B | $3.33B | $5.52B |
| FY2025 | $64.50B | $-3.27B | $5.23B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $75.96B | $15.41B | $9.75B |
| FY2022 | $63.13B | $17.25B | $9.20B |
| FY2023 | $59.25B | $10.36B | $12.81B |
| FY2024 | $66.84B | $3.33B | $5.52B |
| FY2025 | $64.50B | $-3.27B | $5.23B |